- Home
- MSN vs GLMD Comparison
MSN vs GLMD Comparison
Compare MSN & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSN
- GLMD
- Stock Information
- Founded
- MSN 1948
- GLMD 2000
- Country
- MSN United States
- GLMD Israel
- Employees
- MSN N/A
- GLMD N/A
- Industry
- MSN Consumer Electronics/Appliances
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- MSN Consumer Staples
- GLMD Health Care
- Exchange
- MSN Nasdaq
- GLMD Nasdaq
- Market Cap
- MSN 9.3M
- GLMD 8.1M
- IPO Year
- MSN 1994
- GLMD 2014
- Fundamental
- Price
- MSN $0.42
- GLMD $1.27
- Analyst Decision
- MSN
- GLMD Hold
- Analyst Count
- MSN 0
- GLMD 1
- Target Price
- MSN N/A
- GLMD N/A
- AVG Volume (30 Days)
- MSN 344.5K
- GLMD 229.8K
- Earning Date
- MSN 08-14-2025
- GLMD 08-28-2025
- Dividend Yield
- MSN N/A
- GLMD N/A
- EPS Growth
- MSN N/A
- GLMD N/A
- EPS
- MSN N/A
- GLMD N/A
- Revenue
- MSN $10,262,000.00
- GLMD N/A
- Revenue This Year
- MSN N/A
- GLMD N/A
- Revenue Next Year
- MSN N/A
- GLMD N/A
- P/E Ratio
- MSN N/A
- GLMD N/A
- Revenue Growth
- MSN 8.49
- GLMD N/A
- 52 Week Low
- MSN $0.28
- GLMD $1.15
- 52 Week High
- MSN $0.59
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- MSN 45.38
- GLMD 34.04
- Support Level
- MSN $0.32
- GLMD $1.33
- Resistance Level
- MSN $0.44
- GLMD $1.63
- Average True Range (ATR)
- MSN 0.05
- GLMD 0.12
- MACD
- MSN -0.01
- GLMD -0.01
- Stochastic Oscillator
- MSN 34.78
- GLMD 7.69
About MSN Emerson Radio Corporation
Emerson Radio Corp operates in the consumer electronics industry. The company designs, sources, imports, and markets a variety of houseware and consumer electronic products, and licenses the Emerson trademark domestically and internationally. The products offered by the company are televisions, digital versatile disc players and video cassette recorders, audio accessories, microwave ovens, home theatres, high-end audio products, office products, mobile stereo, and wireless products.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.